The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The ever‐increasing importance of cancer as a leading cause of premature death worldwide
Open accessAbstract
The relative importance of cardiovascular disease (CVD) and cancer as leading causes of premature death are examined in this communication. CVD and cancer are now the leading causes in 127 countries, with CVD leading in 70 countries (including Brazil and India) and cancer leading in 57 countries (including China). Such observations can be seen as part of a late phase of an epidemiologic transition, taking place in the second half of the 20th century and the first half of the present one, in which the dominance of infectious diseases is progressively superseded by noncommunicable diseases. According to present ranks and recent trends, cancer may surpass CVD as the leading cause of premature death in most countries over the course of this century. Clearly, governments must factor in these transitions in developing cancer policies for the local disease profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4
Bennett, J. E., Kontis, V., Mathers, C. D., Guillot, M., Rehm, J., Chalkidou, K., Kengne, A. P., Carrillo-Larco, R. M., Bawah, A. A., Dain, K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31761-x · Cited by 447
Bray, F., & Soerjomataram, I. (2015) · Disease Control Priorities, Third Edition (Volume 3): Cancer · doi:10.1596/978-1-4648-0349-9_ch2 · Cited by 209
Self-citationGelband, H., Sankaranarayanan, R., Gauvreau, C. L., Horton, S., Anderson, B. O., Bray, F., Cleary, J., Dare, A. J., Denny, L., Gospodarowicz, M. K., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00755-2 · Cited by 205
Self-citationNational cancer control plans: a global analysis
Romero, Y., Trapani, D., Johnson, S., Tittenbrun, Z., Given, L., Hohman, K., Stevens, L., Torode, J. S., Boniol, M., & Ilbawi, A. M. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30681-8 · Cited by 199
Cancer mortality in Europe, 1990–1994, and an overview of trends from 1955 to 1994
Levi, F., Lucchini, F., Negri, E., Boyle, P., & Vecchia, C. L. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00154-9 · Cited by 150
Core elements of national cancer control plans: a tool to support plan development and review
Oar, A. J., de Moraes, F. Y., Romero, Y., Ilbawi, A., & Yap, M. L. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30404-8 · Cited by 64
World Population Prospects 2019 - Volume II: Demographic Profiles
Nations, U. (2020) · doi:10.18356/7707d011-en · Cited by 46
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationBray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Self-citationCancer statistics in China and United States, 2022: profiles, trends, and determinants
Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., Yang, F., Yan, X., Zhang, S., Li, N., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002108 · Cited by 3,402
Janesick, A., Shelansky, R., Gottscho, A. D., Wagner, F., Williams, S. R., Rouault, M., Beliakoff, G., Morrison, C. A., Oliveira, M. F., Sicherman, J. T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43458-x · Cited by 909
Anjum, S., Hashim, M., Malik, S. A., Khan, M., Lorenzo, J. M., Abbasi, B. H., & Hano, C. (2021) · Cancers · doi:10.3390/cancers13184570 · Cited by 575
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019
Kang, M. J., Won, Y.-J., Lee, J. J., Jung, K.-W., Kim, H.-J., Kong, H.-J., Im, J.-S., Seo, H. G., & Registries, T. C. O. P.-B. R. C. (2022) · Cancer Research and Treatment · doi:10.4143/crt.2022.128 · Cited by 385
Aggregation-Induced Emission (AIE), Life and Health
Wang, H., Li, Q., Alam, P., Bai, H., Bhalla, V., Bryce, M. R., Cao, M., Chen, C., Chen, S., Chen, X., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c03925 · Cited by 385
Understanding and targeting resistance mechanisms in cancer
Lei, Z., Tian, Q., Teng, Q., Wurpel, J. N. D., Zeng, L., Pan, Y., & Chen, Z. (2023) · MedComm · doi:10.1002/mco2.265 · Cited by 347
Cardiovascular disease and cancer: shared risk factors and mechanisms
Wilcox, N. S., Amit, U., Reibel, J. B., Berlin, E., Howell, K., & Ky, B. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01017-x · Cited by 310
Mitochondria: It is all about energy
Casanova, A., Wevers, A., Navarro-Ledesma, S., & Pruimboom, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1114231 · Cited by 303
Bray, F., Parkin, D. M., Gnangnon, F., Tshisimogo, G., Peko, J.-F., Adoubi, I., Assefa, M., Bojang, L., Awuah, B., Koulibaly, M., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00270-4 · Cited by 282
Self-citationMolecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
Gu, Y., Yang, R., Zhang, Y., Guo, M., Takehiro, K., Zhan, M., Yang, L., & Wang, H. (2025) · Molecular Biomedicine · doi:10.1186/s43556-024-00239-2 · Cited by 184
Soerjomataram, I., Cabasag, C., Bardot, A., Fidler-Benaoudia, M. M., Miranda-Filho, A., Ferlay, J., Parkin, D. M., Ranganathan, R., Piñeros, M., Znaor, A., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00704-5 · Cited by 128
Self-citationAlmeida, M., Ramos, C., Maciel, L., Basto-Pereira, M., & Leal, I. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.995981 · Cited by 81
“Meaning-centered interventions are mostly applied to advance or terminal cancer patients (Breitbart, 2002; Mok et al., 2012; Guerrero-Torrelles et al., 2017; Kang et al., 2019).”
BackgroundTargeting glycolysis in non-small cell lung cancer: Promises and challenges
Xu, J.-Q., Fu, Y.-L., Zhang, J., Zhang, K.-Y., Ma, J., Tang, J.-Y., Zhang, Z.-W., & Zhou, Z.-Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1037341 · Cited by 75
Li, Q., He, G., Yu, Y., Li, X., Peng, X., & Yang, L. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04061-z · Cited by 64
Li, C.-L., Fang, Z.-X., Wu, Z., Hou, Y.-Y., Wu, H.-T., & Liu, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113616 · Cited by 46
RetractedAssociation between ultra-processed foods and risk of cancer: a systematic review and meta-analysis
Lian, Y., Wang, G.-P., Chen, G.-Q., Chen, H.-N., & Zhang, G.-Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1175994 · Cited by 45
Zhang, D., Wang, T., Zhou, Y., & Zhang, X. (2023) · Medicine · doi:10.1097/md.0000000000033468 · Cited by 28
Arch, J. J., Bright, E. E., Finkelstein, L. B., Fink, R. M., Mitchell, J. L., Andorsky, D. J., & Kutner, J. S. (2023) · JCO Oncology Practice · doi:10.1200/op.23.00287 · Cited by 25
Gut Microbiota–Related Biomarkers in Immuno-Oncology
Silva, C. A. C., Fidelle, M., Almonte, A. A., Derosa, L., & Zitvogel, L. (2025) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061124-102218 · Cited by 22
Rine, S., Lara, S. T., Bikomeye, J. C., Beltrán-Ponce, S., Kibudde, S., Niyonzima, N., Lawal, O. O., Mulamira, P., & Beyer, K. M. (2023) · Journal of Global Health · doi:10.7189/jogh.13.06048 · Cited by 16
Seyrafi, N., Homayuni, A., Hosseini, Z., Aghamolaei, T., Ghanbarnejad, A., & Mouseli, A. (2022) · BMC Cancer · doi:10.1186/s12885-022-10331-x · Cited by 22
Protein kinase inhibitors as therapeutics in neurodegenerative and psychiatric disorders
Tridente, G., Jana, A., Nath, A., & Ashraf, G. M. (2023) · Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders · doi:10.1016/b978-0-443-18677-6.00015-4 · Cited by 8
Advances in 2,3-Dimethylmaleic Anhydride (DMMA)-Modified Nanocarriers in Drug Delivery Systems
Wan, D., Wu, Y., Liu, Y., Liu, Y., & Pan, J. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060809 · Cited by 7
Reimagining cancer treatments in the era of generative AI
Derbal, Y. (2025) · DIGITAL HEALTH · doi:10.1177/20552076251394631 · Cited by 4
Kan, X., Wang, J., Li, Y., Li, D., Li, F., Huang, C., & Liu, P. (2026) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2025.115397 · Cited by 3
Kulkarni Kale, U., & Vemulapalli, G. (2025) · The Cancer Journal · doi:10.1097/ppo.0000000000000799 · Cited by 1
Metadata
- Authors
- Bray, F., Laversanne, M., Weiderpass, E., & Soerjomataram, I.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2021-06-04
- Volume
- 127
- Issue
- 16
- Pages
- 3029-3030
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W3165720345
- Cited by
- 2,591
- References
- 7
- FWCI
- 130.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.